1. Home
  2. RBCAA vs PHAR Comparison

RBCAA vs PHAR Comparison

Compare RBCAA & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Republic Bancorp Inc.

RBCAA

Republic Bancorp Inc.

HOLD

Current Price

$76.44

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.46

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBCAA
PHAR
Founded
1974
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
RBCAA
PHAR
Price
$76.44
$16.46
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
N/A
$38.33
AVG Volume (30 Days)
69.7K
8.0K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
2.40%
N/A
EPS Growth
N/A
N/A
EPS
0.77
N/A
Revenue
$417,495,000.00
N/A
Revenue This Year
$3.93
$10.04
Revenue Next Year
N/A
$2.51
P/E Ratio
$97.52
$3,041.22
Revenue Growth
8.50
N/A
52 Week Low
$63.97
$8.39
52 Week High
$78.00
$21.34

Technical Indicators

Market Signals
Indicator
RBCAA
PHAR
Relative Strength Index (RSI) 59.37 45.92
Support Level $66.20 $16.35
Resistance Level $76.74 $17.49
Average True Range (ATR) 2.37 0.47
MACD 0.11 -0.10
Stochastic Oscillator 85.28 2.50

Price Performance

Historical Comparison
RBCAA
PHAR

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking, which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending, and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans, and receipt and payment of federal.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: